| Term 
 | Definition 
 
        |   Major molecular targets: – components of the GABA system •GABAA receptors,  •GAT-1 GABA transporter •GABA transaminase – voltage-gated Na+ channels – voltage-gated Ca2+ channels |  | 
        |  | 
        
        | Term 
 
        | Generalized Seizures (convulsive or non-convulsive)
 |  | Definition 
 
        |   •Tonic-clonic  seizures •Absence (petit mal) •Atonic seizures •Myoclonic seizures |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   SIMPLE •Manifestations without loss of consciousness. •Motor, sensory, vegetative or psychic. •Seizure-symptoms don’t change during seizure.   COMPLEX (temporal lobe seizures…psychomotor) •Bizarre attacks of confused behavior •Usually preceded by a warning sensation (“aura”) •Usually an impairment of consciousness Patient will remember little of attack |  | 
        |  | 
        
        | Term 
 
        | Anticonvulsants   General Adverse Effects: |  | Definition 
 
        |   •CNS depression (most common) •Dizziness, sedation, impaired learning and cognitive abilities   •GI •Anorexia, nausea, vomiting   •Skin •Mild rash to Stevens-Johnson syndrome (rare) |  | 
        |  | 
        
        | Term 
 
        | Anticonvulsants   Classic First Generation Drugs |  | Definition 
 
        |   •Carbamazepine •Valproate •Phenytoin |  | 
        |  | 
        
        | Term 
 
        | Anticonvulsants   New Second Generation Drugs |  | Definition 
 
        |   •Lamotrigine •Topiramate •Levetiracetam •Pregabalin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Mechanism of action: –limits repetitive firing of action potentials •blocks voltage-activated Na+ channels  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Absorption, distribution and metabolism: –water insoluble; oral only –T½ 36hrs (initial); 8-12hrs (continuous)   –extensively bound to plasma proteins (75-85%) –induces its own metabolism in liver via CYP450 –carbamazepine-10,11-epoxide is active metabolite |  | 
        |  | 
        
        | Term 
 
        | Carbamazepine Unique Adverse Effects: |  | Definition 
 
        |   –hematological disorders •aplastic anemia and agranulocytosis •usually occurs within 4 months of initiation or increase in dose –drug interactions due to CYP450 induction –dry mouth, glossitis and stomatitis –in children, need to emphasize oral hygiene •63% sugar in chewable tablet |  | 
        |  | 
        
        | Term 
 
        | Valproate    Mechanism of action: |  | Definition 
 
        |   –may enhance GABA function •via synthesis, transport and metabolism –may limit repetitive firing of action potentials blocks voltage-activated Na+ channels   |  | 
        |  | 
        
        | Term 
 
        | Valproate Absorption, distribution and metabolism |  | Definition 
 
        |   –water soluble; well absorbed –T½ 9-18hrs   –extensively bound to plasma proteins (85-95%) metabolized in liver via oxidation/glucuronidation |  | 
        |  | 
        
        | Term 
 
        | Valproate Unique Adverse Effects |  | Definition 
 
        |   –hepatotoxicity •risk is greatest in patients under 2-years of age •polytherapy –hypersalivation –inhibits 2nd phase of platelet aggregation –drug interactions •related to plasma protein binding sites •potent inhibitor of oxidation and glucuronidation |  | 
        |  | 
        
        | Term 
 
        | Phenytoin   Mechanism of action: |  | Definition 
 
        |   –limits repetitive firing of action potentials by producing a sustained depolarization •blocks voltage-activated Na+ channels  |  | 
        |  | 
        
        | Term 
 
        | Phenytoin Absorption, distribution and metabolism |  | Definition 
 
        |   –exhibits zero-order kinetics –T½ 12-36hrs (avg. of 24hrs)   –extensively bound to plasma proteins (70-95%) –no active metabolites |  | 
        |  | 
        
        | Term 
 
        | Phenytoin   Unique Adverse Effects: |  | Definition 
 
        |   –gingival hyperplasia –hirsutism –teratogenicity •“Fetal Hydantoin Syndrome” –growth deficiency with microcephaly, hypoplasia of the nails and distal phalanges. –cardiac defects and abnormal genitalia –drug interactions •displaces other drugs due to plasma protein binding can alter the metabolism of other drugs |  | 
        |  | 
        
        | Term 
 
        | Lamotrigine Mechanism of action |  | Definition 
 
        |   –limits repetitive firing of action potentials by producing a sustained depolarization •blocks voltage-activated Na+ and Ca2+ channels •inhibition of glutamate release |  | 
        |  | 
        
        | Term 
 
        | Lamotrigine   Absorption distribution, metabolism   |  | Definition 
 
        |   •low plasma protein binding •T½ 24hrs (valproate doubles)   |  | 
        |  | 
        
        | Term 
 
        | Topiramate   Mechanism of action: |  | Definition 
 
        |   –limits repetitive firing of action potentials  •blocks voltage-activated Na+ and Ca2+ channels •inhibition of glutamate release •enhances GABA  |  | 
        |  | 
        
        | Term 
 
        | Topiramate Absorption, distribution and metabolism |  | Definition 
 
        | Rapidly absorbed; bioavailability is almost 100%; no active metabolites; excreted in urine |  | 
        |  | 
        
        | Term 
 
        | Topiramate Unique Adverse Effects |  | Definition 
 
        |   –kidney stones (inhibition of carbonic anhydrase) |  | 
        |  | 
        
        | Term 
 
        | Levetiracetam   Mechanism of action: |  | Definition 
 
        |   –blockade of a brain-specific, stereo-selective binding site known as the synaptic vesicular protein (SV2A) •important for the availability of Ca2+-dependent neurotransmitter vesicles (glutamate and/or GABA) •inhibition of Ca2+ release from IP3-sensitive stores |  | 
        |  | 
        
        | Term 
 
        | Levetiracetam          Absorption, distribution    and           metabolism: |  | Definition 
 
        | Rapidly absorbed; bioavailability is almost 100%; no active metabolites; excreted in urine |  | 
        |  | 
        
        | Term 
 
        | Pregabalin (and Gabapentin)
   Mechanism of action: |  | Definition 
 
        |   –do not act on GABA receptors, but may alter its metabolism, release and transport binds to the α2δ subunit of the voltage-gated Ca2+ channel (but are not channel blockers…reduces neurotransmitter release) |  | 
        |  | 
        
        | Term 
 
        | Pregabalin (and Gabapentin)
   Absorption, distribution and metabolism: |  | Definition 
 
        |   –Rapidly absorbed; bioavailability is greater than 90%; no active metabolites; excreted in urine. |  | 
        |  | 
        
        | Term 
 
        | Benzodiazepines   approved by FDA for treatment of epilepsy: |  | Definition 
 
        |    
–Clonazepam –Clorazepate –Diazepam – tablets and injectable DOC->>>status epilepticus –Lorazepam – injectable |  | 
        |  | 
        
        | Term 
 
        | Ethosuximide   Mechanism of action: |  | Definition 
 
        |   –reduces low-threshold Ca2+ currents (T-type) in thalamic neurons possible effect on K+channels |  | 
        |  | 
        
        | Term 
 
        | Ethosuximide Absorption, distribution and metabolism |  | Definition 
 
        | Rapidly and completely absorbed; no active metabolites; excreted in urine. |  | 
        |  | 
        
        | Term 
 
        | Treatment of SeizuresPartial Seizures
 DOC |  | Definition 
 
        |   SIMPLE and COMPLEX,     •Carbamazepine  •Phenytoin •Valproate      Alternatives:   Lamotrigine,  Pregabalin,  Topiramate,    Levetiracetam.        |  | 
        |  | 
        
        | Term 
 
        | Treatment of SeizuresGeneralized Seizures
 DOC |  | Definition 
 
        |   TONIC-CLONIC SEIZURES (Grand Mal)   •Carbamazepine •Phenytoin •Valproate*     Alternatives:   Lamotrigine,  Pregabalin,  Topiramate,    Levetiracetam.      *Not approved except if absence seizure is involved    |  | 
        |  | 
        
        | Term 
 
        | Treatment of Seizures Status Epilepticus
 |  | Definition 
 
        |   Initial: •Diazepam (intra-rectal gel) –effects only last 5-15 minutes •Lorazepam –effects last 2-8 hours   Follow-up: •Phenytoin –takes 15-30 minutes to work |  | 
        |  |